Donate Now Download Brochure
Donate Now Download Brochure

Transforming Breast Cancer Care

Through Innovation, Collaboration and Education

IBDK is a non-profit institution addressing inequities in breast cancer care across India and other low- and middle-income countries. Through research, education, and patient-centered innovation, we strengthen early detection, appropriate treatment, and continuity of care. Our work is guided by a simple principle: breast cancer outcomes should be shaped by evidence and equity—not by access, income, or geography.
$ Learn More

Transforming Breast Cancer Care

Through Innovation, Collaboration and Education

IBDK is a non-profit institution addressing inequities in breast cancer care across India and other low- and middle-income countries. Through research, education, and patient-centered innovation, we strengthen early detection, appropriate treatment, and continuity of care. Our work is guided by a simple principle: breast cancer outcomes should be shaped by evidence and equity—not by access, income, or geography.
$ Learn More

Transforming Breast Cancer Care

Through Innovation, Collaboration and Education

IBDK is a non-profit institution addressing inequities in breast cancer care across India and other low- and middle-income countries. Through research, education, and patient-centered innovation, we strengthen early detection, appropriate treatment, and continuity of care. Our work is guided by a simple principle: breast cancer outcomes should be shaped by evidence and equity—not by access, income, or geography.
$ Learn More

Our Brand Ambassador

At IBDK, we are honoured to be represented by a voice whose life’s work embodies courage, advocacy, and transformative leadership. As our Brand Ambassador, Prof. Rangina Hamidi brings powerful global insight and a deep commitment to education and equity-resonating with IBDK’s mission to humanise cancer care across communities and borders.

Professor

Rangina Hamidi

Rangina Hamidi is a prominent Afghan educator, women’s rights advocate, and former Minister of Education of Afghanistan-the first woman to hold the post in over 30 years. She is the founder of Kandahar Treasure, the first women-owned social enterprise in southern Afghanistan, empowering women through economic independence and cultural preservation. With a degree in religious studies and gender from the University of Virginia, she has
spent over two decades working at the intersection of education, development, and gender equity. A published author and global speaker, Hamidi continues to advise international organizations on education policy and women’s empowerment in conflict-affected regions.

Professor

Bhramar Mukherjee

Professor Bhramar Mukherjee is the Anna M.R. Lauder Professor of Biostatistics and Professor of Chronic Disease Epidemiology at the Yale School of Public Health (YSPH). She serves as the inaugural Senior Associate Dean for Public Health Data Science and Data Equity at YSPH. In addition, she holds a secondary appointment in
the Department of Statistics and Data Science and is affiliated with the MacMillan Center and the Institute for the Foundations of Data Science. Professor Mukherjee also serves on the Yale Cancer Center Director’s Cabinet. Beyond academia, she is an avid theatre enthusiast with deep ties to literature and culture.

Director’s Message

Dr. Soumen Das

Founding Director, Institute of Breast Diseases, Kolkata

Cancer should never be a verdict written by one’s poverty or postcode. Yet, for millions in lowand middle-income countries, the barriers of cost and access remain as lethal as the disease itself. Every individual – regardless of geography, income, or social standing – deserves the dignity of timely, quality care.

The Institute of Breast Diseases, Kolkata (IBDK) was born from this conviction. We exist to challenge the systemic disparities that define cancer care in LMICs and to develop solutions forged in thecrucible of resource constraints. History has shown that innovation emerging from scarcity often sets the standard for progress. We hope the answers we discover here can change the trajectory of cancer care everywhere.

Brand Advocate

Dr. Poulami Basu

Medical Oncologist

Dr. Poulami Basu, MBBS, MD, DM (Medical Oncology). She is a Consultant Medical Oncologist at Netaji Subhas Chandra Bose Cancer Hospital, Kolkata. Her expertise includes Medical and Hemato-Oncology, Immunotherapy, and Targeted Therapy.

Patient Care
Courses
Toolkits
Projects
News & Events

Book a Second Opinion

Confused about a diagnosis or treatment plan? Get your case reviewed by IBDK’s multidisciplinary Tumour Board for clear, evidence-based guidance.
$ Learn More

Navigator Support

A survivor-led patient navigation programme that helps patients move smoothly through diagnosis, treatment, and recovery.
Designed to reduce delays, prevent drop-outs, and ensure continuity of care.
$ Learn More

Featured Courses

Strengthening clinical thinking through focused, practice-oriented learning.

Explore our featured courses designed for surgical trainees and early-career clinicians.

$ Learn More

ME App

ME App is a digital self-care and early symptom tracking tool designed to support breast health awareness and timely help-seeking. It empowers users to monitor symptoms, perform regular self-checks, and seek medical guidance when needed.

$ Learn More

Investigator Sign-Up

We invite clinicians, researchers, and healthcare professionals to participate in IBDK’s ongoing and upcoming research projects.
Join us as an investigator or study participant and contribute to research grounded in real clinical settings.

$ Join as Investigator / Participant

Collaborate With Us

IBDK works with hospitals, academic institutions, research organisations, and partners to develop and implement impactful breast cancer initiatives.
If you are interested in collaborating on research, training, or innovation projects, we would like to hear from you.

$ Collaborate With Us

Media Coverage

Media mentions.

$ Learn More

Announcements

Official announcements.

Global Collaborations

IBDK actively collaborates with leading national and international organisations working in cancer research, policy, and care delivery.